The information on this page is the latest information and resources for Community Pharmacies.

Coronavirus Health Information Line: 1800 020 080

Healthdirect Hotline: 1800 022 222

Expand each section below for further information


Electronic Prescribing

Commencement of Poisons and Therapeutic Goods Amendment (Prescriptions) Regulation 2020

Community pharmacists in NSW can now dispense a prescription for most medicines using an image of the prescription received by email or fax, rather than requiring a paper prescription.

This temporary measure will better support patients, prescribers and pharmacists during the COVID-19 response, and allow better integration of the prescription and supply of medicines with the Commonwealth Government’s COVID-19 response telehealth reforms.

Supply on the Image of a Prescription and additions to Appendix D

Telehealth scripts (excl. S4D and S8) when transmitted as an image do not need the original paper based prescription to be sent to the pharmacy from now until 4th April 2021.

The steps for image-based prescribing and dispensing are:

  1. Prescriber issues a prescription, including a physical handwritten signature
  2. Prescriber sends an image-based prescription to the patient’s pharmacy of choice by email or fax
  • The prescriber should indicate that the original has been retained by them

Pharmacist dispenses the prescription, prints a copy and endorses it as per usual Pharmacist arranges delivery or pick up by the patient, carer or patient's agent Pharmacist keeps any repeats and all prescriptions for two years. Does NOT apply to S4D and S8 prescriptions All repeats must be supplied and held in the same pharmacy as the original supply. For a prescription issued with repeats, print the repeat authorisation form as normal and attach it to the printed copy of the image-based prescription and store them together at the pharmacy for future dispensing.

There are no changes to issuing and dispensing prescriptions for S4D and S8 medicines. A prescriber may still direct a pharmacist to dispense S8 and S4D medicines by telephone, email or fax, and the paper-based prescription must be sent to the pharmacist within 24 hours.

As a reminder, the following medicines are now included in Appendix D as prescribed restricted substances (S4D):

  • pregabalin
  • quetiapine
  • tramadol
  • zolpidem
  • zopiclone

 

NSW Health Image-Based Prescriptions for Community Pharmacies Information

NSW Health Prescription Advice for Pharmacists

Department of Health - Electronic Prescribing Information


Masks

Pharmacy staff are advised to not wear face masks as a precautionary measure.

P2/N95 respirator masks are not required to be worn by patients without symptoms unless they are immunocompromised and have been directed to do so by their treating specialist.

Unless masks are used correctly they are unlikely to protect against airborne pathogen spread.

PUTTING ON A MASK

REMOVING A MASK

PRINCIPLES OF FIT-CHECKING

Principles of Fit-Checking

CEC COVID-19 PPE TRAINING VIDEOS

CEC BASIC PPE TRAINING VIDEOS

PPE Application and Removal Safety Sequence

Returning To Work Post-Isolation

A joint statement from the Communicable Diseases Network Australia (CDNA) and Public Health Laboratory Network (PHLN) with the revised Australian criteria for the release from isolation of people who have recovered from COVID-19.

Criteria for the Release of Persons Recovered from COVID-19


Information from Pharmaceutical Society of Australia


Advice for Immunisation Services During COVID-19

Updated advice has been provided by NSW Health to assist with planning and managing vaccinations clinics while coinciding with the COVID-19 response.


Immunisation providers should continue to offer immunisation services with enhanced infection control measures.

Advice for Immunisation Services During COVID-19

Note: WNSW PHN is monitoring the COVID-19 situation daily and update and develop our pathways and links accordingly.

If you identify any errors or inconsistencies or are aware of any new or emerging critical changes that are relevant, please email the Media & Communications Coordinator.